Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biosimilar Rituximab in Systemic Lupus Erythematosus
NCT03054259Phase 2Unknown
- Sponsor
- University of Leeds
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in systemic lupus erythematosus (SLE), sponsored by University of Leeds. Status: unknown.
02
Drugs
rituximab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03054259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054259.